
22.2
PPG
8.4
RPG
5.2
APG
0.7
SPG
0.6
BPG
4592.0%
FG%
3054.5%
3P%
7745.8%
FT%
| Season | Team | GP | MIN | PTS | REB | AST | STL | BLK | TO | FG% | 3P% | FT% | TS% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025–26 | ORL | 72 | 34.7 | 22.2 | 8.4 | 5.2 | 0.7 | 0.6 | 3.1 | 45.9% | 30.5% | 77.5% | 56.6% |
| 2024–25 | ORL | 46 | 34.4 | 25.9 | 7.5 | 4.8 | 0.8 | 0.6 | 3.0 | 45.2% | 32.0% | 72.7% | 55.1% |
| 2023–24 | ORL | 81 | 34.8 | 22.3 | 7.0 | 5.4 | 0.9 | 0.6 | 3.0 | 45.4% | 33.5% | 72.5% | 54.5% |
| 2022–23 | ORL | 72 | 33.8 | 20.0 | 6.9 | 3.7 | 0.8 | 0.5 | 2.8 | 42.7% | 29.8% | 73.8% | 52.9% |
| Season | Team | GP | MIN | PTS | REB | AST | STL | BLK | TO | FG% | 3P% | FT% | TS% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025–26 | ORL | 7 | 39.0 | 26.3 | 9.0 | 6.3 | 1.4 | 0.7 | 3.4 | 42.0% | 33.3% | 67.6% | 52.4% |
| 2024–25 | ORL | 5 | 39.4 | 29.4 | 8.4 | 4.2 | 0.6 | 0.8 | 3.0 | 43.5% | 44.4% | 65.9% | 51.7% |
| 2023–24 | ORL | 7 | 37.4 | 27.0 | 8.6 | 4.0 | 1.1 | 0.6 | 4.6 | 45.6% | 40.0% | 75.5% | 55.4% |